HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Infantile Hemangioma: Clinical Characteristics and Efficacy of Treatment with the Long-Pulsed 1,064-nm Neodymium-Doped Yttrium Aluminum Garnet Laser in 794 Chinese Patients.

AbstractOBJECTIVE:
This study aimed to evaluate the clinical characteristics of infantile hemangiomas (IHs) and the safety and efficacy of the long-pulse 1,064-nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for definitive treatment of IHs in 794 Chinese patients.
METHODS:
Infants with hemangiomas who had received long-pulse 1,064-nm Nd:YAG laser treatment in our department in the last 5 years were recruited. Demographic and clinical characteristics were recorded and outcomes of long-pulse 1,064-nm Nd:YAG laser treatment were assessed. Statistical analyses were performed to identify factors that affected the efficacy of treatment.
RESULTS:
The efficacy of long-pulse 1,064-nm Nd:YAG laser for the treatment of IHs in all patients in our study was 87.57%. Efficacy did not depend on sex or the location of the lesion. Older age and superficial hemangioma were the primary factors contributing to greater efficacy of long-pulse 1,064-nm Nd:YAG laser treatment for IHs. The most common side effects were pigment changes, skin atrophy, and wrinkled redundant skin, which usually resolved spontaneously within 1 to 3 years.
CONCLUSIONS:
Long-pulse 1,064-nm Nd:YAG laser is a safe and efficacious treatment for IHs.
AuthorsShu-xia Zhong, Yu-chun Tao, Jun-feng Zhou, Yuan-yuan Liu, Lei Yao, Shan-shan Li
JournalPediatric dermatology (Pediatr Dermatol) 2015 Jul-Aug Vol. 32 Issue 4 Pg. 495-500 ISSN: 1525-1470 [Electronic] United States
PMID25950113 (Publication Type: Journal Article)
Copyright© 2015 Wiley Periodicals, Inc.
Topics
  • Female
  • Hemangioma, Capillary (radiotherapy)
  • Humans
  • Infant
  • Infant, Newborn
  • Laser Therapy (methods)
  • Lasers, Solid-State
  • Male
  • Skin Neoplasms (radiotherapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: